These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 17240107)
61. A Retrospective Analysis of Anaerobic Bacteria Isolated in 236 Cases of Pleural Empyema and their Prevalance of Antimicrobial Resistance in Turkey. Demirci M; Gemicioglu B; Saribas S; Taner Z; Mamal-Torun M; Karatoka B; Asik-Cagli L; Guven O; Demiryas S; Kocazeybek BS; Bahar-Tokman H Clin Lab; 2018 Jul; 64(7):1269-1277. PubMed ID: 30146848 [TBL] [Abstract][Full Text] [Related]
62. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis. Werner H; Heizmann WR; Höflsauer M Infection; 1991; 19(5):377-9. PubMed ID: 1800380 [TBL] [Abstract][Full Text] [Related]
73. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species. Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431 [TBL] [Abstract][Full Text] [Related]
74. Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole. Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1997 May; 41(5):1037-41. PubMed ID: 9145865 [TBL] [Abstract][Full Text] [Related]
75. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. Behra-Miellet J; Dubreuil L; Jumas-Bilak E Int J Antimicrob Agents; 2002 Nov; 20(5):366-74. PubMed ID: 12431872 [TBL] [Abstract][Full Text] [Related]
76. Antimicrobial susceptibility patterns of clinically significant Gram-positive anaerobic bacteria in a Greek tertiary-care hospital, 2017-2019. Maraki S; Mavromanolaki VE; Stafylaki D; Kasimati A Anaerobe; 2020 Aug; 64():102245. PubMed ID: 32707228 [TBL] [Abstract][Full Text] [Related]
77. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Citron DM; Merriam CV; Tyrrell KL; Warren YA; Fernandez H; Goldstein EJ Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492 [TBL] [Abstract][Full Text] [Related]
78. BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials. Wootton M; Bowker KE; Holt HA; MacGowan AP J Antimicrob Chemother; 2002 Mar; 49(3):535-9. PubMed ID: 11864955 [TBL] [Abstract][Full Text] [Related]
79. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Sutter VL; Finegold SM Antimicrob Agents Chemother; 1976 Oct; 10(4):736-52. PubMed ID: 984809 [TBL] [Abstract][Full Text] [Related]
80. Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria. Wüst J; Hardegger U Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):946-9. PubMed ID: 1486894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]